首页|左乙拉西坦片仿制药与原研药治疗儿童癫痫的疗效、安全性比较

左乙拉西坦片仿制药与原研药治疗儿童癫痫的疗效、安全性比较

扫码查看
目的:研究住院环境下儿童癫痫患者使用左乙拉西坦片仿制药与原研药以及在两者之间切换使用的临床结果,探讨门诊环境下左乙拉西坦片原研药的转换与回切。方法:对2020年1月至2022年6月于该院住院并接受左乙拉西坦片250 mg治疗的125例儿童癫痫患者进行回顾性队列研究。计算使用仿制药及原研药患者的发作频率减少率,汇总并分析在两个品种间切换的患者的特征,并进一步随访原研药在门诊的转换与回切率。结果:125例癫痫患者中,原研药组患者的癫痫控制率为87。50%(63/72),仿制药组为83。02%(44/53),两组的差异无统计学意义(P>0。05);患者联合用药数量增加将降低癫痫控制率(OR=0。333,95%CI=0。114~0。969,P=0。044)。报告的4例不良反应均来自原研药组单药治疗的患者,分别为情绪不稳(2例)、皮疹(2例)。入组患者中,14例存在原研及仿制药品种间切换的情况,在控制性别、年龄及治疗特征时,患者入院次数(OR=2。7,95%CI=1。506~4。791,P=0。001)、癫痫控制情况(OR=0。07,95%CI=0。009~0。555,P=0。012)与品种切换相关。门诊随访过程中,原研药的累积转换率为50。05%,校正累积回切率为20。29%。结论:本研究队列中,原研与仿制左乙拉西坦片对癫痫儿童的疗效和安全性无差异,药物品种的切换更多出现在入院次数增加和癫痫未控制的情况下。尽管仿制药物已在门诊普及,原研药物仍存在固定的使用人群。
Comparison of Efficacy and Safety of Generic and Original Levetiracetam in the Treatment of Epilepsy in Children
OBJECTIVE:To investigate the clinical outcomes of generic and original Levetiracetam tablets and the switching in children with epilepsy during hospitalization,so as to explore the switching and switching-back of generic and original Levetiracetam tablets in outpatient setting.METHODS:Retrospective cohort study was performed on 125 children with epilepsy admitted into the hospital and received 250 mg of Levetiracetam tablets from Jan.2020 to Jun.2022.The reduction rates of seizure frequency of children using generic and originator drugs were calculated,the characteristics of children who switched generic and original Levetiracetam tablets were summarized and analyzed,further follow-up was conducted on the switching and switching-back of original drugs in outpatient.RESULTS:Among the 125 children with epilepsy,the epilepsy control rate was 87.50%(63/72)in the original drug group and 83.02%(44/53)in the generic drug group,the difference was not statistically significant(P>0.05),while the increase of number of drug combination would decrease the epilepsy control rate(OR=0.333,95%CI=0.114-0.969,P=0.044).Four reports of adverse drug reactions were all from patients received monotherapy in the original drug group,which were respectively emotional lability(2 cases)and rash(2 cases).Fourteen cases of the enrolled children had variety switching between original and generic drugs,the number of hospital admissions(OR=2.7,95%CI=1.506-4.791,P=0.001)and epilepsy control(OR=0.07,95%CI=0.009-0.555,P=0.012)were correlated with the drug variety switching when controlling gender,age and treatment characteristics.During outpatient follow-up,the cumulative switching rate was 50.05%and the corrected cumulative switching-back rate was 20.29%of the original drugs.CONCLUSIONS:There are no differences in efficacy and safety between original and generic Levetiracetam tablets in children with epilepsy in this study cohort,the drug variety switching occurs more frequently under increased hospital admissions and uncontrolled epilepsy.Despite the popularization of generic drugs in outpatient setting,there is still a fixed population using original drugs.

Original drugsGeneric drugsLevetiracetam tabletsChildren with epilepsyEfficacySafety

颜颖慧、王凤娇、王文娟、朱增燕

展开 >

苏州大学附属儿童医院药剂科,江苏苏州 215025

原研药 仿制药 左乙拉西坦片 儿童癫痫 疗效 安全性

江苏省药学会天晴医院药学科研项目江苏省药学会奥赛康医院药学科研项目

Q202021A202122

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(1)
  • 14